Search - tctmd.com

Displaying 881 - 900 of 2044

Sort: Relevancy | Date

News Industry News

Medtronic Avalus(TM) Surgical Aortic Valve Shows Positive Outcomes in One-Year Clinical Trial Results

October 04, 2016

News Daily News

No Differences Between Bivalirudin, Unfractionated Heparin in ACS Patients With or Without ST Elevation: MATRIX

Shelley Wood

October 03, 2016

News Daily News

Ipsilateral Ulnar Compression Significantly Reduces Risk of Radial Artery Occlusion After Transradial PCI

Michael O'Riordan

October 03, 2016

News Daily News

Heavy Burden of Residual Thrombus After Thrombectomy Signals Worse Primary PCI Results

Todd Neale

October 03, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2016

Shelley Wood

September 30, 2016

News Daily News

TCTMD’s Top 10 Most Popular Stories for September 2016

Shelley Wood

September 30, 2016

News Industry News

Edwards INSPIRIS RESILIA Valve Receives CE Mark

September 29, 2016

News Conference News VIVA 2016

Bioresorbable Scaffold Shows Sustained Promise in Superficial Femoral and Iliac Artery Lesions

L.A. McKeown

September 22, 2016

News Daily News

Potential Genetic Link Between Platelet Activity and Cardiovascular Disease Identified

Michael O'Riordan

September 22, 2016

News Conference News VIVA 2016

Long PAD Lesions Respond Well to DCB, but Optimal Patient Selection Still Unclear

L.A. McKeown

September 21, 2016

News Conference News PCR London Valves 2016

TAVR vs SAVR: Limitations and Risks Debated as Transcatheter Therapies Move Into Younger and Lower-Risk Patients

Shelley Wood

September 20, 2016

News Conference News PCR London Valves 2016

Leaflet Restriction After TAVR: Two Hospitals Tracking Patients Find Similar Rates of the Phenomenon

Shelley Wood

September 20, 2016

News Daily News

比伐卢定？肝素？研究显示医师在选择 STEMI 患者 PCI 方案时存在分歧

Yael L. Maxwell

September 15, 2016

News Daily News

¿Bivalirudina?, ¿Heparina? Una Encuesta Revela que los Médicos se Dividen por las Opciones Antitrombóticas para PCI en el Manejo de STEMI

Yael L. Maxwell

September 15, 2016

News Daily News

Bivalirudin? Heparin? Physicians Are Divided Over Antithrombotic Choices for PCI in STEMI, Survey Shows

Yael L. Maxwell

September 15, 2016

News Daily News

Stroke Risk With TAVR: In-Depth Review of PARTNER and CoreValve Data Reveals Opportunities and Unknowns

Shelley Wood

September 13, 2016

News Conference News ESC 2016

Valve Thrombosis After TAVR Linked to Larger Device Size, Lack of Warfarin Therapy

Todd Neale

September 02, 2016

News Conference News ESC 2016

Simplified VTE Protocol Rules Out Pulmonary Embolism, Reduces Use of CT Imaging: YEARS Study

Michael O'Riordan

September 02, 2016

News Industry News

FDA Approves New AGGRASTAT® Product Format

September 01, 2016

News Conference News ESC 2016

Day or Night, STEMI Patients Receive Similar Levels of Quality Care

L.A. McKeown

August 31, 2016

Advertisement

Medtronic Avalus(TM) Surgical Aortic Valve Shows Positive Outcomes in One-Year Clinical Trial Results

No Differences Between Bivalirudin, Unfractionated Heparin in ACS Patients With or Without ST Elevation: MATRIX

Ipsilateral Ulnar Compression Significantly Reduces Risk of Radial Artery Occlusion After Transradial PCI

Heavy Burden of Residual Thrombus After Thrombectomy Signals Worse Primary PCI Results

TCTMD’s Top 10 Most Popular Stories for September 2016

TCTMD’s Top 10 Most Popular Stories for September 2016

Edwards INSPIRIS RESILIA Valve Receives CE Mark

Bioresorbable Scaffold Shows Sustained Promise in Superficial Femoral and Iliac Artery Lesions

Potential Genetic Link Between Platelet Activity and Cardiovascular Disease Identified

Long PAD Lesions Respond Well to DCB, but Optimal Patient Selection Still Unclear

TAVR vs SAVR: Limitations and Risks Debated as Transcatheter Therapies Move Into Younger and Lower-Risk Patients

Leaflet Restriction After TAVR: Two Hospitals Tracking Patients Find Similar Rates of the Phenomenon

比伐卢定？肝素？研究显示医师在选择 STEMI 患者 PCI 方案时存在分歧

¿Bivalirudina?, ¿Heparina? Una Encuesta Revela que los Médicos se Dividen por las Opciones Antitrombóticas para PCI en el Manejo de STEMI

Bivalirudin? Heparin? Physicians Are Divided Over Antithrombotic Choices for PCI in STEMI, Survey Shows

Stroke Risk With TAVR: In-Depth Review of PARTNER and CoreValve Data Reveals Opportunities and Unknowns

Valve Thrombosis After TAVR Linked to Larger Device Size, Lack of Warfarin Therapy

Simplified VTE Protocol Rules Out Pulmonary Embolism, Reduces Use of CT Imaging: YEARS Study

FDA Approves New AGGRASTAT® Product Format

Day or Night, STEMI Patients Receive Similar Levels of Quality Care

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content